Solana Co (HSDT): Nasdaq/NYSE listing notice — Helius Medical faces Nasdaq delisting; to appeal, sets 2025 annual meeting for April 21

Solana Co

Received Nasdaq delisting notice on Feb 7, 2025 for continued bid price below $1; intends to appeal, hearing stays delisting.
On Jan 21, 2025, entered warrant inducement to exercise existing warrants at $0.751/share for 4.97M shares, issuing new warrants for up to 6.21M shares pending stockholder approval.
2025 Annual Meeting set for April 21, 2025; record date March 12, 2025; stockholder proposal and director nomination deadline is Feb 17, 2025.
No assurance of regaining compliance; common stock remains listed on Nasdaq pending hearing outcome.

item 3.01 item 5.08 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Solana Co received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 7, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common stock would be delisted from The Nasdaq Capital Market unless the Company appeals the Staff’s delisting determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company’s request for a hearing will stay any further delisting action by the Staff pending the ultimate outcome of the hearing. The Company’s common stock will remain listed and eligible

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Solana Co received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 7, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common s

View on SEC.gov

Browse all listing & compliance notices →

Solana Co filing history →

Source: SEC EDGAR

accession 0001558370-25-000717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.